Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Reversible chemoresistance of pancreatic cancer grown as spheroids.
Journal: Journal of chemotherapy (Florence, Italy)
Published: September 16, 2024
SREBP-Dependent Regulation of Lipid Homeostasis Is Required for Progression and Growth of Pancreatic Ductal Adenocarcinoma.
Journal: Cancer research communications
Published: February 25, 2024
SREBP-dependent regulation of lipid homeostasis is required for progression and growth of pancreatic ductal adenocarcinoma.
Journal: bioRxiv : the preprint server for biology
Published: February 19, 2024
Trastuzumab Deruxtecan‒Related Interstitial Lung Disease/Pneumonitis: Computed Tomography Imaging Patterns to Guide Diagnosis and Management.
Journal: JCO precision oncology
Published: December 07, 2023
Phase 2 study of vismodegib, a hedgehog inhibitor, combined with gemcitabine and nab-paclitaxel in patients with untreated metastatic pancreatic adenocarcinoma.
Journal: British journal of cancer
Published: February 05, 2019
Ezrin Promotes Stem Cell Properties in Pancreatic Ductal Adenocarcinoma.
Journal: Molecular cancer research : MCR
Published: April 14, 2018
YAP1 and COX2 Coordinately Regulate Urothelial Cancer Stem-like Cells.
Journal: Cancer research
Published: March 24, 2017
The extracellular matrix and focal adhesion kinase signaling regulate cancer stem cell function in pancreatic ductal adenocarcinoma.
Journal: PloS one
Published: December 20, 2016
Circulating Tumor Cells Expressing Markers of Tumor-Initiating Cells Predict Poor Survival and Cancer Recurrence in Patients with Pancreatic Ductal Adenocarcinoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 13, 2016
Circulating Tumor Cell Phenotype Predicts Recurrence and Survival in Pancreatic Adenocarcinoma.
Journal: Annals of surgery
Published: January 13, 2016
Last Updated: 09/26/2026